183 related articles for article (PubMed ID: 22271424)
1. Enhancement of intestinal permeability utilizing solid lipid nanoparticles increases γ-tocotrienol oral bioavailability.
Abuasal BS; Lucas C; Peyton B; Alayoubi A; Nazzal S; Sylvester PW; Kaddoumi A
Lipids; 2012 May; 47(5):461-9. PubMed ID: 22271424
[TBL] [Abstract][Full Text] [Related]
2. Enhanced solubility and oral bioavailability of γ-tocotrienol using a self-emulsifying drug delivery system (SEDDS).
Alqahtani S; Alayoubi A; Nazzal S; Sylvester PW; Kaddoumi A
Lipids; 2014 Aug; 49(8):819-29. PubMed ID: 24934591
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the intestinal absorption and bioavailability of γ-tocotrienol and α-tocopherol: in vitro, in situ and in vivo studies.
Abuasal BS; Qosa H; Sylvester PW; Kaddoumi A
Biopharm Drug Dispos; 2012 Jul; 33(5):246-56. PubMed ID: 22528033
[TBL] [Abstract][Full Text] [Related]
4. Intestinal absorption of gamma-tocotrienol is mediated by Niemann-Pick C1-like 1: in situ rat intestinal perfusion studies.
Abuasal B; Sylvester PW; Kaddoumi A
Drug Metab Dispos; 2010 Jun; 38(6):939-45. PubMed ID: 20207946
[TBL] [Abstract][Full Text] [Related]
5. Surface modification of solid lipid nanoparticles for oral delivery of curcumin: Improvement of bioavailability through enhanced cellular uptake, and lymphatic uptake.
Baek JS; Cho CW
Eur J Pharm Biopharm; 2017 Aug; 117():132-140. PubMed ID: 28412471
[TBL] [Abstract][Full Text] [Related]
6. Potential of Lipid Nanoparticles (SLNs and NLCs) in Enhancing Oral Bioavailability of Drugs with Poor Intestinal Permeability.
Talegaonkar S; Bhattacharyya A
AAPS PharmSciTech; 2019 Feb; 20(3):121. PubMed ID: 30805893
[TBL] [Abstract][Full Text] [Related]
7. Nonlinear absorption kinetics of self-emulsifying drug delivery systems (SEDDS) containing tocotrienols as lipophilic molecules: in vivo and in vitro studies.
Alqahtani S; Alayoubi A; Nazzal S; Sylvester PW; Kaddoumi A
AAPS J; 2013 Jul; 15(3):684-95. PubMed ID: 23572242
[TBL] [Abstract][Full Text] [Related]
8. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles.
Yuan H; Chen CY; Chai GH; Du YZ; Hu FQ
Mol Pharm; 2013 May; 10(5):1865-73. PubMed ID: 23495754
[TBL] [Abstract][Full Text] [Related]
9. Enhanced bioavailability of tripterine through lipid nanoparticles using broccoli-derived lipids as a carrier material.
Li W; Zhang T; Ye Y; Zhang X; Wu B
Int J Pharm; 2015 Nov; 495(2):948-55. PubMed ID: 26453780
[TBL] [Abstract][Full Text] [Related]
10. A study to enhance the oral bioavailability of s-adenosyl-l-methionine (SAMe): SLN and SLN nanocomposite particles.
Amasya G; Ergin AD; Erkan Cakirci O; Ozçelikay AT; Sezgin Bayindir Z; Yuksel N
Chem Phys Lipids; 2021 Jul; 237():105086. PubMed ID: 33930379
[TBL] [Abstract][Full Text] [Related]
11. A new formulation of Gamma Delta Tocotrienol has superior bioavailability compared to existing Tocotrienol-Rich Fraction in healthy human subjects.
Meganathan P; Jabir RS; Fuang HG; Bhoo-Pathy N; Choudhury RB; Taib NA; Nesaretnam K; Chik Z
Sci Rep; 2015 Sep; 5():13550. PubMed ID: 26323969
[TBL] [Abstract][Full Text] [Related]
12. Influence of route of administration on the absorption and disposition of alpha-, gamma- and delta-tocotrienols in rats.
Yap SP; Yuen KH; Lim AB
J Pharm Pharmacol; 2003 Jan; 55(1):53-8. PubMed ID: 12625867
[TBL] [Abstract][Full Text] [Related]
13. Colloidal lipid nanodispersion enriched hydrogel of antifungal agent for management of fungal infections: Comparative in-vitro, ex-vivo and in-vivo evaluation for oral and topical application.
Dudhipala N; Ali Youssef AA; Banala N
Chem Phys Lipids; 2020 Nov; 233():104981. PubMed ID: 33031802
[TBL] [Abstract][Full Text] [Related]
14. PEGylated γ-tocotrienol isomer of vitamin E: Synthesis, characterization, in vitro cytotoxicity, and oral bioavailability.
Abu-Fayyad A; Behery F; Sallam AA; Alqahtani S; Ebrahim H; El Sayed KA; Kaddoumi A; Sylvester PW; Carroll JL; Cardelli JA; Nazzal S
Eur J Pharm Biopharm; 2015 Oct; 96():185-95. PubMed ID: 26235392
[TBL] [Abstract][Full Text] [Related]
15. Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization,
Patel MH; Mundada VP; Sawant KK
Drug Dev Ind Pharm; 2019 Aug; 45(8):1242-1257. PubMed ID: 30880488
[No Abstract] [Full Text] [Related]
16. Preparation and in vitro, in vivo evaluations of norfloxacin-loaded solid lipid nanopartices for oral delivery.
Dong Z; Xie S; Zhu L; Wang Y; Wang X; Zhou W
Drug Deliv; 2011 Aug; 18(6):441-50. PubMed ID: 21554156
[TBL] [Abstract][Full Text] [Related]
17. In-vivo bioavailability and lymphatic uptake evaluation of lipid nanoparticulates of darunavir.
Bhalekar MR; Upadhaya PG; Madgulkar AR; Kshirsagar SJ; Dube A; Bartakke US
Drug Deliv; 2016 Sep; 23(7):2581-2586. PubMed ID: 25996834
[TBL] [Abstract][Full Text] [Related]
18. The enhancement of the oral bioavailability of γ-tocotrienol in mice by γ-cyclodextrin inclusion.
Miyoshi N; Wakao Y; Tomono S; Tatemichi M; Yano T; Ohshima H
J Nutr Biochem; 2011 Dec; 22(12):1121-6. PubMed ID: 21292469
[TBL] [Abstract][Full Text] [Related]
19. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin.
Ji H; Tang J; Li M; Ren J; Zheng N; Wu L
Drug Deliv; 2016; 23(2):459-70. PubMed ID: 24892628
[TBL] [Abstract][Full Text] [Related]
20. Design and evaluation of polymer coated carvedilol loaded solid lipid nanoparticles to improve the oral bioavailability: a novel strategy to avoid intraduodenal administration.
Venishetty VK; Chede R; Komuravelli R; Adepu L; Sistla R; Diwan PV
Colloids Surf B Biointerfaces; 2012 Jun; 95():1-9. PubMed ID: 22463845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
